StockData
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. (AVXL) stock

AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.72−0.02 (-2.78%)

Close on Nov 18, 2026Market cap $66.69MP/E –Yield –

Anavex Life Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2015 it was $332, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2015Sep 30, 2015$332-100.0%
FY2014Sep 30, 2014$5.72M–

More Anavex Life Sciences figures

See a number that looks wrong?